$2.32T
Total marketcap
$107.87B
Total volume
BTC 49.94%     ETH 15.49%
Dominance

Coloplast A/S CLPBF Stock

130 USD {{ price }} -3.169345% {{change_pct}}%
Exchange
Other OTC
Market Cap
29.34B USD
LOW - HIGH [24H]
130 - 130 USD
VOLUME [24H]
50 USD
{{ volume }}
P/E Ratio
40.49
Earnings per share
3.21 USD

Coloplast A/S Price Chart

Coloplast A/S CLPBF Financial and Trading Overview

Coloplast A/S stock price 130 USD
Previous Close 121.9 USD
Open 122.24 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 121.9 - 121.9 USD
52 Week Range 95.75 - 145.05 USD
Volume 366 USD
Avg. Volume 71 USD
Market Cap 26.03B USD
Beta (5Y Monthly) 0.283908
PE Ratio (TTM) 37.27829
EPS (TTM) 3.21 USD
Forward Dividend & Yield 2.85 (2.33%)
Ex-Dividend Date May 15, 2023
1y Target Est 16.13 USD

CLPBF Valuation Measures

Enterprise Value 46.9B USD
Trailing P/E 37.27829
Forward P/E 29.58738
PEG Ratio (5 yr expected) 163.43
Price/Sales (ttm) 1.081094
Price/Book (mrq) 3.681111
Enterprise Value/Revenue 1.948
Enterprise Value/EBITDA 6.034

Trading Information

Coloplast A/S Stock Price History

Beta (5Y Monthly) 0.283908
52-Week Change 18.07%
S&P500 52-Week Change 20.43%
52 Week High 145.05 USD
52 Week Low 95.75 USD
50-Day Moving Average 133.09 USD
200-Day Moving Average 119.88 USD

CLPBF Share Statistics

Avg. Volume (3 month) 71 USD
Avg. Daily Volume (10-Days) 100 USD
Shares Outstanding 194.31M
Float 130.82M
Short Ratio N/A
% Held by Insiders 35.90%
% Held by Institutions 26.33%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 20
Trailing Annual Dividend Yield 16.40%
5 Year Average Dividend Yield 200.99%
Payout Ratio 0.885
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends September 30, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End September 30, 2023

Profitability

Profit Margin 19.94%
Operating Margin (ttm) 29.19%
Gross Margin 68.08%
EBITDA Margin 32.28%

Management Effectiveness

Return on Assets (ttm) 12.46%
Return on Equity (ttm) 67.11%

Income Statement

Revenue (ttm) 24.07B USD
Revenue Per Share (ttm) 113.37 USD
Quarterly Revenue Growth (yoy) 10.19%
Gross Profit (ttm) 15.53B USD
EBITDA 7.77B USD
Net Income Avi to Common (ttm) 4.8B USD
Diluted EPS (ttm) 3.27
Quarterly Earnings Growth (yoy) 17.89%

Balance Sheet

Total Cash (mrq) 644M USD
Total Cash Per Share (mrq) 3.03 USD
Total Debt (mrq) 21.65B USD
Total Debt/Equity (mrq) 307.76 USD
Current Ratio (mrq) 0.988
Book Value Per Share (mrq) 33.115

Cash Flow Statement

Operating Cash Flow (ttm) 4.89B USD
Levered Free Cash Flow (ttm) 3.36B USD

Profile of Coloplast A/S

Country United States
State N/A
City Humlebæk
Address Holtedam 1-3
ZIP 3050
Phone 45 49 11 11 11
Website https://www.coloplast.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 14973

Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, it offers voice and respiratory products, including medical devices for neck stoma under the Provox brand; and products for tracheostoma under the TRACOE brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Q&A For Coloplast A/S Stock

What is a current CLPBF stock price?

Coloplast A/S CLPBF stock price today per share is 130 USD.

How to purchase Coloplast A/S stock?

You can buy CLPBF shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Coloplast A/S?

The stock symbol or ticker of Coloplast A/S is CLPBF.

Which industry does the Coloplast A/S company belong to?

The Coloplast A/S industry is Medical Instruments & Supplies.

How many shares does Coloplast A/S have in circulation?

The max supply of Coloplast A/S shares is 225.7M.

What is Coloplast A/S Price to Earnings Ratio (PE Ratio)?

Coloplast A/S PE Ratio is 40.49844400 now.

What was Coloplast A/S earnings per share over the trailing 12 months (TTM)?

Coloplast A/S EPS is 3.21 USD over the trailing 12 months.

Which sector does the Coloplast A/S company belong to?

The Coloplast A/S sector is Healthcare.